COVID-19 - CISMeF

CISMeF

chu

COVID-19MeSH Descriptor

Preferred Label : COVID-19;

Obsolete resource : false;

MeSH definition : A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent.;

MeSH synonym : COVID 19; COVID-19 Virus Disease; COVID 19 Virus Disease; COVID-19 Virus Diseases; Disease, COVID-19 Virus; Virus Disease, COVID-19; COVID-19 Virus Infection; COVID 19 Virus Infection; COVID-19 Virus Infections; Infection, COVID-19 Virus; Virus Infection, COVID-19; 2019-nCoV Infection; 2019 nCoV Infection; 2019-nCoV Infections; Infection, 2019-nCoV; Coronavirus Disease-19; Coronavirus Disease 19; 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019-nCoV Disease; 2019 nCoV Disease; 2019-nCoV Diseases; Disease, 2019-nCoV; COVID19; Coronavirus Disease 2019; Disease 2019, Coronavirus; SARS Coronavirus 2 Infection; SARS-CoV-2 Infection; Infection, SARS-CoV-2; SARS CoV 2 Infection; SARS-CoV-2 Infections; Severe Acute Respiratory Syndrome Coronavirus 2 Infection;

Related MeSH term : COVID 19 Pandemic; COVID-19 Pandemics; Pandemic, COVID-19;

Wikipedia link : https://en.wikipedia.org/wiki/Covid 19 pandemic;

Details

Origin ID

D000086382;

UMLS CUI

C5203670;

ATC code(s)
- covid-19, RNA-based vaccine [ATC Code]
- covid-19, inactivated virus [ATC Code]
- covid-19, protein subunit [ATC Code]
Allowable qualifiers
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemically induced [MeSH Qualifier]
- classification [MeSH Qualifier]
- complications [MeSH Qualifier]
- congenital [MeSH Qualifier]
- diagnosis [MeSH Qualifier]
- diagnostic imaging [MeSH Qualifier]
- diet therapy [MeSH Qualifier]
- drug therapy [MeSH Qualifier]
- economics [MeSH Qualifier]
- embryology [MeSH Qualifier]
- enzymology [MeSH Qualifier]
- epidemiology [MeSH Qualifier]
- ethnology [MeSH Qualifier]
- etiology [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- microbiology [MeSH Qualifier]
- mortality [MeSH Qualifier]
- nursing [MeSH Qualifier]
- parasitology [MeSH Qualifier]
- pathology [MeSH Qualifier]
- physiopathology [MeSH Qualifier]
- prevention and control [MeSH Qualifier]
- psychology [MeSH Qualifier]
- radiotherapy [MeSH Qualifier]
- rehabilitation [MeSH Qualifier]
- surgery [MeSH Qualifier]
- therapy [MeSH Qualifier]
- transmission [MeSH Qualifier]
- urine [MeSH Qualifier]
- veterinary [MeSH Qualifier]
- virology [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- COVID-19 [ICD-11 Category]
- Coronavirus Disease 2019 [LOINC component]
- Infected with SARS-CoV-2 [NCIt concept]
- Meningococcal A [UNVA Disease]
- covid-19 (coronavirus disease 2019) [MedlinePlus Topic]
Currated CISMeF NLP mapping
- 2019 novel coronavirus infection [MedDRA LLT]
- 2019-nCoV infection [MedDRA LLT]
- COVID-19 [MedDRA Preferred Term]
- COVID-19 [DO Concept]
- COVID-19 [ICD-10 Sub-category]
- COVID-19 Infection [NCIt concept]
- COVID-19, virus identified [ICD-11 Subcategory]
- Coronavirus disease 2019 [MedDRA LLT]
- Disease caused by severe acute respiratory syndrome coronavirus 2 (disorder) [SNOMED CT concept]
- SARS-CoV-2 infection [MedDRA LLT]
- coronavirus disease 2019 [COVID-19 Thesaurus concept]
DO Cross reference
- COVID-19 [DO Concept]
Indexing information
- bamlanivimab and etesevimab drug combination [MeSH Supplementary Concept]
Record concept(s)
- COVID-19 [MeSH concept]
- COVID-19 Pandemic [MeSH concept]
Related MeSH Supplementary Concept(s)
- COVID-19 breakthrough infections [MeSH Supplementary Concept]
- COVID-19 post-intensive care syndrome [MeSH Supplementary Concept]
- COVID-19 rebound [MeSH Supplementary Concept]
- COVID-19 reinfection [MeSH Supplementary Concept]
- COVID-19 stress syndrome [MeSH Supplementary Concept]
- COVID-19 stress syndrome [MeSH Supplementary Concept]
- adult multisystem inflammatory disease, COVID-19 related [MeSH Supplementary Concept]
- pediatric multisystem inflammatory disease, COVID-19 related [MeSH Supplementary Concept]
- pediatric multisystem inflammatory disease, COVID-19 related [MeSH Supplementary Concept]
Related MeSH term(s)
- COVID-19 Drug Treatment [MeSH Descriptor]
See also
- SARS-CoV-2 [MeSH Descriptor]
See also (suggested by CISMeF)
- COVID-19 Vaccines [MeSH Descriptor]
- SARS-CoV-2 [MeSH Descriptor]
- bamlanivimab [MeSH Supplementary Concept]
- casirivimab [MeSH Supplementary Concept]
- casirivimab and imdevimab drug combination [MeSH Supplementary Concept]
- etesevimab [MeSH Supplementary Concept]
- imdevimab [MeSH Supplementary Concept]
- remdesivir [MeSH Supplementary Concept]
- sotrovimab [MeSH Supplementary Concept]
See also inter- (CISMeF)
- COVID-19-Associated Acute Respiratory Distress Syndrome [NCIt concept]
- Casirivimab/Imdevimab [NCIt concept]
- Convalescent Plasma [NCIt concept]
- Covid-19 convalescent plasma therapy [COVID-19 Thesaurus concept]
- Product containing precisely sotrovimab 62.5 milligram/1 milliliter conventional release solution for injection (clinical drug) [SNOMED CT concept]
- Regdanvimab [NCIt concept]
- convalescent plasma [SYNODOS term]
- cytokine storm syndrome in COVID-19 [Indication]
Semantic type(s)
- Disease or Syndrome [UMLS semantic type]
UMLS correspondences (same concept)
- 2019 novel coronavirus infection [MedDRA LLT]
- 2019-nCoV infection [MedDRA LLT]
- COVID-19 [MedDRA Preferred Term]
- COVID-19 [ICD-10 Sub-category]
- COVID-19 [DO Concept]
- COVID-19 Infection [NCIt concept]
- Coronavirus Disease 2019 [LOINC component]
- Coronavirus disease 2019 [MedDRA LLT]
- Disease caused by severe acute respiratory syndrome coronavirus 2 (disorder) [SNOMED CT concept]
- SARS-CoV-2 infection [MedDRA LLT]
- covid-19 (coronavirus disease 2019) [MedlinePlus Topic]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients

Nous contacter.
18/05/2024

© Rouen University Hospital. Any partial or total use of this material must mention the source.

COVID-19 - CISMeF

CISMeF

chu

COVID-19MeSH Descriptor

Preferred Label : COVID-19;

Obsolete resource : false;

MeSH definition : A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent.;

MeSH synonym : COVID 19; COVID-19 Virus Disease; COVID 19 Virus Disease; COVID-19 Virus Diseases; Disease, COVID-19 Virus; Virus Disease, COVID-19; COVID-19 Virus Infection; COVID 19 Virus Infection; COVID-19 Virus Infections; Infection, COVID-19 Virus; Virus Infection, COVID-19; 2019-nCoV Infection; 2019 nCoV Infection; 2019-nCoV Infections; Infection, 2019-nCoV; Coronavirus Disease-19; Coronavirus Disease 19; 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019-nCoV Disease; 2019 nCoV Disease; 2019-nCoV Diseases; Disease, 2019-nCoV; COVID19; Coronavirus Disease 2019; Disease 2019, Coronavirus; SARS Coronavirus 2 Infection; SARS-CoV-2 Infection; Infection, SARS-CoV-2; SARS CoV 2 Infection; SARS-CoV-2 Infections; Severe Acute Respiratory Syndrome Coronavirus 2 Infection;

Related MeSH term : COVID 19 Pandemic; COVID-19 Pandemics; Pandemic, COVID-19;

Wikipedia link : https://en.wikipedia.org/wiki/Covid 19 pandemic;

Details

Origin ID

D000086382;

UMLS CUI

C5203670;

ATC code(s)
- covid-19, RNA-based vaccine [ATC Code]
- covid-19, inactivated virus [ATC Code]
- covid-19, protein subunit [ATC Code]
Allowable qualifiers
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemically induced [MeSH Qualifier]
- classification [MeSH Qualifier]
- complications [MeSH Qualifier]
- congenital [MeSH Qualifier]
- diagnosis [MeSH Qualifier]
- diagnostic imaging [MeSH Qualifier]
- diet therapy [MeSH Qualifier]
- drug therapy [MeSH Qualifier]
- economics [MeSH Qualifier]
- embryology [MeSH Qualifier]
- enzymology [MeSH Qualifier]
- epidemiology [MeSH Qualifier]
- ethnology [MeSH Qualifier]
- etiology [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- microbiology [MeSH Qualifier]
- mortality [MeSH Qualifier]
- nursing [MeSH Qualifier]
- parasitology [MeSH Qualifier]
- pathology [MeSH Qualifier]
- physiopathology [MeSH Qualifier]
- prevention and control [MeSH Qualifier]
- psychology [MeSH Qualifier]
- radiotherapy [MeSH Qualifier]
- rehabilitation [MeSH Qualifier]
- surgery [MeSH Qualifier]
- therapy [MeSH Qualifier]
- transmission [MeSH Qualifier]
- urine [MeSH Qualifier]
- veterinary [MeSH Qualifier]
- virology [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- COVID-19 [ICD-11 Category]
- Coronavirus Disease 2019 [LOINC component]
- Infected with SARS-CoV-2 [NCIt concept]
- Meningococcal A [UNVA Disease]
- covid-19 (coronavirus disease 2019) [MedlinePlus Topic]
Currated CISMeF NLP mapping
- 2019 novel coronavirus infection [MedDRA LLT]
- 2019-nCoV infection [MedDRA LLT]
- COVID-19 [MedDRA Preferred Term]
- COVID-19 [DO Concept]
- COVID-19 [ICD-10 Sub-category]
- COVID-19 Infection [NCIt concept]
- COVID-19, virus identified [ICD-11 Subcategory]
- Coronavirus disease 2019 [MedDRA LLT]
- Disease caused by severe acute respiratory syndrome coronavirus 2 (disorder) [SNOMED CT concept]
- SARS-CoV-2 infection [MedDRA LLT]
- coronavirus disease 2019 [COVID-19 Thesaurus concept]
DO Cross reference
- COVID-19 [DO Concept]
Indexing information
- bamlanivimab and etesevimab drug combination [MeSH Supplementary Concept]
Record concept(s)
- COVID-19 [MeSH concept]
- COVID-19 Pandemic [MeSH concept]
Related MeSH Supplementary Concept(s)
- COVID-19 breakthrough infections [MeSH Supplementary Concept]
- COVID-19 post-intensive care syndrome [MeSH Supplementary Concept]
- COVID-19 rebound [MeSH Supplementary Concept]
- COVID-19 reinfection [MeSH Supplementary Concept]
- COVID-19 stress syndrome [MeSH Supplementary Concept]
- COVID-19 stress syndrome [MeSH Supplementary Concept]
- adult multisystem inflammatory disease, COVID-19 related [MeSH Supplementary Concept]
- pediatric multisystem inflammatory disease, COVID-19 related [MeSH Supplementary Concept]
- pediatric multisystem inflammatory disease, COVID-19 related [MeSH Supplementary Concept]
Related MeSH term(s)
- COVID-19 Drug Treatment [MeSH Descriptor]
See also
- SARS-CoV-2 [MeSH Descriptor]
See also (suggested by CISMeF)
- COVID-19 Vaccines [MeSH Descriptor]
- SARS-CoV-2 [MeSH Descriptor]
- bamlanivimab [MeSH Supplementary Concept]
- casirivimab [MeSH Supplementary Concept]
- casirivimab and imdevimab drug combination [MeSH Supplementary Concept]
- etesevimab [MeSH Supplementary Concept]
- imdevimab [MeSH Supplementary Concept]
- remdesivir [MeSH Supplementary Concept]
- sotrovimab [MeSH Supplementary Concept]
See also inter- (CISMeF)
- COVID-19-Associated Acute Respiratory Distress Syndrome [NCIt concept]
- Casirivimab/Imdevimab [NCIt concept]
- Convalescent Plasma [NCIt concept]
- Covid-19 convalescent plasma therapy [COVID-19 Thesaurus concept]
- Product containing precisely sotrovimab 62.5 milligram/1 milliliter conventional release solution for injection (clinical drug) [SNOMED CT concept]
- Regdanvimab [NCIt concept]
- convalescent plasma [SYNODOS term]
- cytokine storm syndrome in COVID-19 [Indication]
Semantic type(s)
- Disease or Syndrome [UMLS semantic type]
UMLS correspondences (same concept)
- 2019 novel coronavirus infection [MedDRA LLT]
- 2019-nCoV infection [MedDRA LLT]
- COVID-19 [MedDRA Preferred Term]
- COVID-19 [ICD-10 Sub-category]
- COVID-19 [DO Concept]
- COVID-19 Infection [NCIt concept]
- Coronavirus Disease 2019 [LOINC component]
- Coronavirus disease 2019 [MedDRA LLT]
- Disease caused by severe acute respiratory syndrome coronavirus 2 (disorder) [SNOMED CT concept]
- SARS-CoV-2 infection [MedDRA LLT]
- covid-19 (coronavirus disease 2019) [MedlinePlus Topic]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients

Nous contacter.
18/05/2024

© Rouen University Hospital. Any partial or total use of this material must mention the source.

COVID-19 - CISMeF

CISMeF

chu

COVID-19MeSH Descriptor

Preferred Label : COVID-19;

Obsolete resource : false;

MeSH definition : A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent.;

MeSH synonym : COVID 19; COVID-19 Virus Disease; COVID 19 Virus Disease; COVID-19 Virus Diseases; Disease, COVID-19 Virus; Virus Disease, COVID-19; COVID-19 Virus Infection; COVID 19 Virus Infection; COVID-19 Virus Infections; Infection, COVID-19 Virus; Virus Infection, COVID-19; 2019-nCoV Infection; 2019 nCoV Infection; 2019-nCoV Infections; Infection, 2019-nCoV; Coronavirus Disease-19; Coronavirus Disease 19; 2019 Novel Coronavirus Disease; 2019 Novel Coronavirus Infection; 2019-nCoV Disease; 2019 nCoV Disease; 2019-nCoV Diseases; Disease, 2019-nCoV; COVID19; Coronavirus Disease 2019; Disease 2019, Coronavirus; SARS Coronavirus 2 Infection; SARS-CoV-2 Infection; Infection, SARS-CoV-2; SARS CoV 2 Infection; SARS-CoV-2 Infections; Severe Acute Respiratory Syndrome Coronavirus 2 Infection;

Related MeSH term : COVID 19 Pandemic; COVID-19 Pandemics; Pandemic, COVID-19;

Wikipedia link : https://en.wikipedia.org/wiki/Covid 19 pandemic;

Details

Origin ID

D000086382;

UMLS CUI

C5203670;

ATC code(s)
- covid-19, RNA-based vaccine [ATC Code]
- covid-19, inactivated virus [ATC Code]
- covid-19, protein subunit [ATC Code]
Allowable qualifiers
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemically induced [MeSH Qualifier]
- classification [MeSH Qualifier]
- complications [MeSH Qualifier]
- congenital [MeSH Qualifier]
- diagnosis [MeSH Qualifier]
- diagnostic imaging [MeSH Qualifier]
- diet therapy [MeSH Qualifier]
- drug therapy [MeSH Qualifier]
- economics [MeSH Qualifier]
- embryology [MeSH Qualifier]
- enzymology [MeSH Qualifier]
- epidemiology [MeSH Qualifier]
- ethnology [MeSH Qualifier]
- etiology [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- microbiology [MeSH Qualifier]
- mortality [MeSH Qualifier]
- nursing [MeSH Qualifier]
- parasitology [MeSH Qualifier]
- pathology [MeSH Qualifier]
- physiopathology [MeSH Qualifier]
- prevention and control [MeSH Qualifier]
- psychology [MeSH Qualifier]
- radiotherapy [MeSH Qualifier]
- rehabilitation [MeSH Qualifier]
- surgery [MeSH Qualifier]
- therapy [MeSH Qualifier]
- transmission [MeSH Qualifier]
- urine [MeSH Qualifier]
- veterinary [MeSH Qualifier]
- virology [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- COVID-19 [ICD-11 Category]
- Coronavirus Disease 2019 [LOINC component]
- Infected with SARS-CoV-2 [NCIt concept]
- Meningococcal A [UNVA Disease]
- covid-19 (coronavirus disease 2019) [MedlinePlus Topic]
Currated CISMeF NLP mapping
- 2019 novel coronavirus infection [MedDRA LLT]
- 2019-nCoV infection [MedDRA LLT]
- COVID-19 [MedDRA Preferred Term]
- COVID-19 [DO Concept]
- COVID-19 [ICD-10 Sub-category]
- COVID-19 Infection [NCIt concept]
- COVID-19, virus identified [ICD-11 Subcategory]
- Coronavirus disease 2019 [MedDRA LLT]
- Disease caused by severe acute respiratory syndrome coronavirus 2 (disorder) [SNOMED CT concept]
- SARS-CoV-2 infection [MedDRA LLT]
- coronavirus disease 2019 [COVID-19 Thesaurus concept]
DO Cross reference
- COVID-19 [DO Concept]
Indexing information
- bamlanivimab and etesevimab drug combination [MeSH Supplementary Concept]
Record concept(s)
- COVID-19 [MeSH concept]
- COVID-19 Pandemic [MeSH concept]
Related MeSH Supplementary Concept(s)
- COVID-19 breakthrough infections [MeSH Supplementary Concept]
- COVID-19 post-intensive care syndrome [MeSH Supplementary Concept]
- COVID-19 rebound [MeSH Supplementary Concept]
- COVID-19 reinfection [MeSH Supplementary Concept]
- COVID-19 stress syndrome [MeSH Supplementary Concept]
- COVID-19 stress syndrome [MeSH Supplementary Concept]
- adult multisystem inflammatory disease, COVID-19 related [MeSH Supplementary Concept]
- pediatric multisystem inflammatory disease, COVID-19 related [MeSH Supplementary Concept]
- pediatric multisystem inflammatory disease, COVID-19 related [MeSH Supplementary Concept]
Related MeSH term(s)
- COVID-19 Drug Treatment [MeSH Descriptor]
See also
- SARS-CoV-2 [MeSH Descriptor]
See also (suggested by CISMeF)
- COVID-19 Vaccines [MeSH Descriptor]
- SARS-CoV-2 [MeSH Descriptor]
- bamlanivimab [MeSH Supplementary Concept]
- casirivimab [MeSH Supplementary Concept]
- casirivimab and imdevimab drug combination [MeSH Supplementary Concept]
- etesevimab [MeSH Supplementary Concept]
- imdevimab [MeSH Supplementary Concept]
- remdesivir [MeSH Supplementary Concept]
- sotrovimab [MeSH Supplementary Concept]
See also inter- (CISMeF)
- COVID-19-Associated Acute Respiratory Distress Syndrome [NCIt concept]
- Casirivimab/Imdevimab [NCIt concept]
- Convalescent Plasma [NCIt concept]
- Covid-19 convalescent plasma therapy [COVID-19 Thesaurus concept]
- Product containing precisely sotrovimab 62.5 milligram/1 milliliter conventional release solution for injection (clinical drug) [SNOMED CT concept]
- Regdanvimab [NCIt concept]
- convalescent plasma [SYNODOS term]
- cytokine storm syndrome in COVID-19 [Indication]
Semantic type(s)
- Disease or Syndrome [UMLS semantic type]
UMLS correspondences (same concept)
- 2019 novel coronavirus infection [MedDRA LLT]
- 2019-nCoV infection [MedDRA LLT]
- COVID-19 [MedDRA Preferred Term]
- COVID-19 [ICD-10 Sub-category]
- COVID-19 [DO Concept]
- COVID-19 Infection [NCIt concept]
- Coronavirus Disease 2019 [LOINC component]
- Coronavirus disease 2019 [MedDRA LLT]
- Disease caused by severe acute respiratory syndrome coronavirus 2 (disorder) [SNOMED CT concept]
- SARS-CoV-2 infection [MedDRA LLT]
- covid-19 (coronavirus disease 2019) [MedlinePlus Topic]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients

Nous contacter.
18/05/2024

© Rouen University Hospital. Any partial or total use of this material must mention the source.